This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

References
Costa A, Daidone MG, Daprai L, Villa R, Cantu S, Pilotti S et al. (2006). Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression. Cancer Res 66: 8918–8924.
Johnson JE, Gettings EJ, Schwalm J, Pei J, Testa JR, Litwin S et al. (2007). Whole-genome profiling in liposarcomas reveals genetic alterations common to specific telomere maintenance mechanisms. Cancer Res 67: 9221–9228.
Johnson JE, Varkonyi RJ, Schwalm J, Cragle R, Klein-Szanto A, Patchefsky A et al. (2005). Multiple mechanisms of telomere maintenance exist in liposarcomas. Clin Cancer Res 11: 5347–5355.
Lafferty-Whyte K, Bilsland AE, Hoare SF, Burns S, Zaffaroni N, Cairney CJ et al. (2010). TCEAL7 inhibition of c-Myc activity in alternative lengthening of telomeres regulates hTERT expression. Neoplasia 12: 405–414.
Lafferty-Whyte K, Cairney CJ, Will MB, Serakinci N, Daidone MG, Zaffaroni N et al. (2009). A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT. Oncogene 28: 3765–3774.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Keith, W., Lafferty-Whyte, K., Cairney, C. et al. Response to ‘Validating a gene expression signature proposed to differentiate liposarcomas that use different telomere maintenance mechanisms’. Oncogene 31, 267–268 (2012). https://doi.org/10.1038/onc.2011.374
Published:
Issue date:
DOI: https://doi.org/10.1038/onc.2011.374